Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression
Aim: Cisplatin is an effective chemotherapeutic drug, but the application in clinical is greatly limited by its nephrotoxicity. Necrostatin-1 (Nec-1), an inhibitor of RIP1 kinase, has been reported to inhibit RIP-mediated necroptosis. The aim of this study is to detect the protective effects of Nec-...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_90a54b2a5afc44ceb648fe8cac1ebb24 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Yichun Ning |e author |
700 | 1 | 0 | |a Yichun Ning |e author |
700 | 1 | 0 | |a Yichun Ning |e author |
700 | 1 | 0 | |a Yichun Ning |e author |
700 | 1 | 0 | |a Yiqin Shi |e author |
700 | 1 | 0 | |a Yiqin Shi |e author |
700 | 1 | 0 | |a Yiqin Shi |e author |
700 | 1 | 0 | |a Jing Chen |e author |
700 | 1 | 0 | |a Jing Chen |e author |
700 | 1 | 0 | |a Jing Chen |e author |
700 | 1 | 0 | |a Nana Song |e author |
700 | 1 | 0 | |a Nana Song |e author |
700 | 1 | 0 | |a Jieru Cai |e author |
700 | 1 | 0 | |a Jieru Cai |e author |
700 | 1 | 0 | |a Jieru Cai |e author |
700 | 1 | 0 | |a Yi Fang |e author |
700 | 1 | 0 | |a Yi Fang |e author |
700 | 1 | 0 | |a Yi Fang |e author |
700 | 1 | 0 | |a Yi Fang |e author |
700 | 1 | 0 | |a Xiaofang Yu |e author |
700 | 1 | 0 | |a Xiaofang Yu |e author |
700 | 1 | 0 | |a Xiaofang Yu |e author |
700 | 1 | 0 | |a Xiaofang Yu |e author |
700 | 1 | 0 | |a Jun Ji |e author |
700 | 1 | 0 | |a Jun Ji |e author |
700 | 1 | 0 | |a Jun Ji |e author |
700 | 1 | 0 | |a Xiaoqiang Ding |e author |
700 | 1 | 0 | |a Xiaoqiang Ding |e author |
700 | 1 | 0 | |a Xiaoqiang Ding |e author |
700 | 1 | 0 | |a Xiaoqiang Ding |e author |
245 | 0 | 0 | |a Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression |
260 | |b Frontiers Media S.A., |c 2018-04-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2018.00384 | ||
520 | |a Aim: Cisplatin is an effective chemotherapeutic drug, but the application in clinical is greatly limited by its nephrotoxicity. Necrostatin-1 (Nec-1), an inhibitor of RIP1 kinase, has been reported to inhibit RIP-mediated necroptosis. The aim of this study is to detect the protective effects of Nec-1 on the nephrotoxicity of cisplatin and to investigate its renoprotection mechanism.Methods: 8-week-old male C57BL/6 mice were randomly assigned into four groups: Control, Nec-1, Cisplatin, and Cisplatin+Nec-1. Mice were treated with cisplatin with or without Nec-1 pre-treatment. Renal function, histological changes, necroptosis, and apoptotic markers were investigated. NFκB pathway related proteins, proinflammatory cytokines, oxidative stress markers, renal Klotho, and autophagy-related proteins levels were also examined.Results: Renal function and histological data displayed that the treatment with Nec-1 significantly attenuates cisplatin-induced renal damage. The expression of RIPK1/RIPK3/MLKL were significantly enhanced in cisplatin group as compared to the control group (p < 0.05) and was significantly reduced by pre-treatment of Nec-1 (p < 0.05). The level of stress and apoptosis-related protein, including p-JNK, p-c-Jun, p-p38, Bax/Bcl-2 ratio, and caspase-3 showed the similar trend. Pre-treatment with Nec-1 inhibit NFκB signaling, reduced proinflammatory cytokines and oxidative stress, up-regulated renal Klotho, and autophagy-related proteins levels.Conclusion: Our results suggest that Nec-1 could be a potential therapeutic drug against the cisplatin-induced nephrotoxicity through its anti-necroptosis, anti-apoptotic, anti-inflammatory anti-oxidant and retain Klotho expression and activate autophagy effects in the kidney. | ||
546 | |a EN | ||
690 | |a cisplatin | ||
690 | |a Necrostatin-1 | ||
690 | |a necroptosis | ||
690 | |a apoptosis | ||
690 | |a inflammation | ||
690 | |a oxidative stress | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 9 (2018) | |
787 | 0 | |n http://journal.frontiersin.org/article/10.3389/fphar.2018.00384/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/90a54b2a5afc44ceb648fe8cac1ebb24 |z Connect to this object online. |